FDA recommends continuing use of AstraZeneca vax
The FDA has recommended continuing to use the AstraZeneca COVID-19 vaccine in the Philippines, citing expert reviews that conclude the benefits outweigh the risks.
Last week, the country temporarily suspended its use for those under 60 due to blood clot concerns reported abroad.
FDA chief Eric Domingo stated that new guidelines on using the AstraZeneca vaccine will be released within the week, providing information on symptoms to watch out for post-vaccination and when individuals should seek medical consultation.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics